Can hyperemesis gravidarum cause a mildly elevated C-reactive protein (CRP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Hyperemesis Gravidarum Cause Mildly Elevated CRP?

Yes, hyperemesis gravidarum (HG) is associated with elevated C-reactive protein (CRP) levels, reflecting systemic inflammation that occurs as part of the disease pathophysiology.

Evidence for CRP Elevation in HG

Multiple recent studies demonstrate that CRP is elevated in women with HG compared to healthy pregnant controls:

  • CRP levels are significantly higher in HG patients (0.85 mg/dL vs 0.19 mg/dL in controls, p = 0.001), and importantly, CRP correlates with disease severity as measured by the PUQE index 1

  • A 2026 study found that CRP-to-albumin ratio (CAR) was significantly elevated in HG patients and demonstrated good discriminative performance for identifying severe HG 2

  • The 2023 research showed that CRP positively correlates with other markers of HG severity including ketonuria and oxidative stress markers 3

  • A 2025 study confirmed that inflammatory markers including CRP are significantly elevated in HG, though CRP levels did not correlate with ketonuria severity specifically 4

Clinical Significance

The elevation in CRP reflects the systemic inflammatory state that characterizes HG pathophysiology. This is not merely an incidental finding but appears to be mechanistically linked to disease severity:

  • CRP elevation occurs alongside other inflammatory markers (NLR, PLR, SII, PIV) that are all elevated in HG 4, 5
  • The inflammatory response appears to worsen with increasing disease severity 3, 1
  • CRP is part of a broader pattern of inflammatory-nutritional derangement in HG 6

Important Caveats

The 2024 RCOG guideline does not specifically mention CRP as a diagnostic or monitoring tool for HG 7. The guideline focuses on clinical assessment using validated tools (PUQE and HELP scores) and notes that ketonuria should NOT be used to assess severity 7.

While CRP is elevated in HG, it should be interpreted in context:

  • CRP elevation is mild to moderate, not dramatically elevated as in severe bacterial infections
  • CRP is a non-specific marker and other causes of inflammation must be excluded
  • The primary role of CRP appears to be in understanding pathophysiology rather than routine clinical management

Practical Application

When you encounter a mildly elevated CRP in a pregnant woman with severe nausea and vomiting:

  • This finding is consistent with HG and reflects the inflammatory component of the disease
  • Use validated severity assessment tools (PUQE or HELP scores) rather than relying on CRP for clinical decision-making 7
  • Focus on clinical features: inability to eat/drink normally, dehydration signs, and impact on daily functioning 7
  • Check electrolytes, renal function, and thyroid function as recommended by guidelines 7
  • Do not use ketonuria to guide treatment decisions 7

The mild CRP elevation supports the diagnosis but should not drive management decisions, which should be based on validated clinical assessment tools and the patient's functional status.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.